Manager, Site Production Planner and Scheduler
Bristol-Myers Squibb
- Location
- Leiden – NL
- Work model
- On-Site
- Level
- Mid
- H-1B history
- 57 approvals (FY2023)
- Posted
- Sep 11, 2026
About this role
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. Bristol Myers Squibb Netherlands Bristol Myers Squibb has been active in the Dutch market for over 50 years, employing people across a range of activities and business units in Utrecht, The Netherlands. The Netherlands is also home to our first European Cell Therapy facility, located at the Leiden Bio Science Park, the largest life sciences cluster of The Netherlands. This new state of the art facility is focused on commercial manufacturing with capabilities for multi-product Cell Therapy manufacturing. You can become part of this exciting journey. Check out this video if you want to know more about it! The Netherlands has everything it takes to become the medicines hub of Europe, the so-called Boston by the North Sea. As we continue to expand our footprint by building this new site, we are looking to grow our team. Would you like to become an important chain in our worldwide network to bring this new personalized treatment to patients suffering from blood cancer? Join us and be a game changer! For more information about Bristol Myers Squibb Netherlands, visit us at bms.com/nl or careers.bms.com/nl Position Summary The Manager, Site Production Planner and Scheduler is a member of Leiden’s Supply Chain team. You are accountable for the master production schedule for the site and for the efficient releasing of orders to manufacturing while ensuring sufficient materials and capacity are available for the manufacturing plan. Further, the role is responsible for building and developing the scheduling tools, processes, and resource requirements for the manufacturing of clinical and commercial drug products. Your role collaborates with various stakeholders such as site Manufacturing, Quality groups, and Facility & Engineering, and with counterparts from the BMS Global network such as Patient Operations, Patient Allocation and it is a strategic role in the Cell Therapy Manufacturing processes managing all aspects of scheduling and production operations. You ensure patients’ material availability - end-to-end - starting from apheresis collection, through the manufacturing process, until the delivery of the patient material back to the treatment center.
Key Responsibilities
Responsible to create and publish on-time the Site Schedule for Manufacturing Operations and Facility and Engineering associates to determine their organization’s assignments. Responsible to mitigate any scheduling risks that could negatively impact the production schedule by working together with relevant functions to resolve these. Support the S&OP process by providing site-level manufacturing capacities and operational capabilities. Responsible to manage RCCP (Rough Cut Capacity Planning) for assigned product(s). Schedule and forecast manufacturing slot availability with internal and global stakeholders. Create scenario plans to accommodate manufacturing batches and support this process. Participate in Tier meetings to communicate, address and resolve daily operational issues related to scheduling. Primary point of contact for the Manufacturing Operations team to provide support, facilitate operational continuity, and address issues as they arise. Develop, manage, and implement KPI and reporting capabilities. Collaborate with global Business Process Teams in support of modeling and scheduling simulation implementations, such as the to-be-implemented Emerson’s RTMS/Bio-G scheduling platform. Author and update